These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32302445)

  • 1. Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy".
    Coto-Hernández R; Fábregas Ruano MT
    J Thromb Haemost; 2020 Jun; 18(6):1519-1520. PubMed ID: 32302445
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'.
    Tang N
    J Thromb Haemost; 2020 Jun; 18(6):1520-1521. PubMed ID: 32302451
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombocytopenia and coagulation disorders due to COVID 19 infection with concomitant cardiovascular diseases requiring anti-platelet and anticoagulant therapy, which strategy?
    Buioni D; Nardi P; Ruvolo G
    Clin Chim Acta; 2020 Sep; 508():109. PubMed ID: 32417209
    [No Abstract]   [Full Text] [Related]  

  • 4. In Response to "Coagulopathy of Coronavirus Disease 2019".
    Ng J; Fan BE; Chia YW
    Crit Care Med; 2020 Nov; 48(11):e1159-e1160. PubMed ID: 32897666
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated coagulopathy.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
    Canonico ME; Siciliano R; Scudiero F; Sanna GD; Parodi G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):262-264. PubMed ID: 32383737
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
    Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
    CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
    Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on coronavirus disease 2019 associated coagulopathy.
    Yang XH; Li RR; Sun RH; Liu J; Chen DC
    Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
    [No Abstract]   [Full Text] [Related]  

  • 12. More on COVID-19 coagulopathy in Caucasian patients.
    Fogarty H; Townsend L; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Browne P; Bacon CL; Gaule R; Gillett A; Byrne M; Ryan K; O'Connell N; O'Sullivan JM; Conlon N; O'Donnell JS
    Br J Haematol; 2020 Jun; 189(6):1060-1061. PubMed ID: 32400024
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 14. RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19.
    Akima S; McLintock C; Hunt BJ
    J Thromb Haemost; 2020 Aug; 18(8):2057-2058. PubMed ID: 32302442
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
    Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
    J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dealing with COVID-19-associated coagulopathy].
    Klok FA; den Exter PL; Huisman MV; Eikenboom J
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the COVID-19 coagulopathy spectrum.
    Thachil J; Agarwal S
    Anaesthesia; 2020 Nov; 75(11):1432-1436. PubMed ID: 32437586
    [No Abstract]   [Full Text] [Related]  

  • 18. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
    Giusti B; Gori AM; Alessi M; Rogolino A; Lotti E; Poli D; Sticchi E; Bartoloni A; Morettini A; Nozzoli C; Peris A; Pieralli F; Poggesi L; Marchionni N; Marcucci R
    Thromb Haemost; 2020 Aug; 120(8):1233-1236. PubMed ID: 32455440
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coagulopathy and COVID-19. Recommendations for a changing reality].
    Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
    Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.
    Weiss E; Roux O; Moyer JD; Paugam-Burtz C; Boudaoud L; Ajzenberg N; Faille D; de Raucourt E
    Thromb Haemost; 2020 Sep; 120(9):1343-1345. PubMed ID: 32645725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.